Why PSMA Imaging Matters in Advanced Prostate Cancer
Prostate-specific membrane antigen (PSMA) is a protein found on the surface of many prostate cancer cells, and PSMA PET imaging uses a small amount of radioactive tracer that attaches to PSMA, allowing a PET scan to highlight areas where prostate cancer may be present. Compared with traditional CT and bone scans, PSMA PET can often detect smaller amounts of prostate cancer and more precisely show where disease has spread.
In advanced prostate cancer, this information can be particularly valuable. A PSMA PET scan may help determine how much cancer is present, where it is located, whether the disease has progressed, and whether certain treatments, including PSMA-targeted radioligand therapy, may be appropriate. In some situations, finding only a small number of metastatic sites may also influence decisions about radiation or other targeted treatments.
Patients may hear their cancer described as “PSMA-positive.” In general, this means that areas of cancer show enough PSMA uptake on the scan to be visible with PSMA PET. However, PSMA expression can vary between patients and even among tumors within the same patient. Importantly, a positive spot on PSMA PET does not automatically determine what treatment should come next. PSMA PET imaging is one piece of the treatment puzzle. Your care team will interpret the scan alongside your PSA, symptoms, previous treatments, other imaging, health, and treatment goals to determine the most appropriate next step.
What Your Care Team May Learn from a PSMA Scan
When your care team reviews a PSMA PET scan, they are looking at more than whether the scan is simply “positive” or “negative.” They want to understand where prostate cancer may be located, how much disease is visible, and the overall pattern of cancer throughout the body. PSMA PET can identify areas of suspected prostate cancer in the prostate or prostate bed, lymph nodes, bones, and organs such as the liver or lungs. The location and number of these areas can provide important information.
For example, a scan may show that cancer remains limited to a small number of sites or that it has spread more widely. It may also identify disease in places that were not visible on a CT or bone scans. This more detailed picture can help your care team better understand the extent of your cancer and consider which treatment approaches may be appropriate. Not every area that takes up the PSMA tracer is necessarily prostate cancer, and very small or PSMA-negative tumors may not appear on the scan. Your team therefore interprets PSMA PET together within the overall context of your prostate cancer.
How Imaging Results May Influence Treatment Conversations
PSMA imaging can provide information that helps your care team discuss not only what treatment may be appropriate, but also when and where treatment might be used. For example, a scan showing cancer in only a few areas may lead to a conversation about whether those individual sites could be treated with targeted radiation. More widespread disease may support discussion of systemic treatments that reach cancer throughout the body. The location of disease may also influence how your doctors think about treatment selection and sequencing. Importantly, PSMA imaging is only one part of this decision.
PSMA imaging can also help determine whether certain additional treatment options should be considered. One important example is PSMA-targeted radioligand therapy, which delivers radiation directly to PSMA-expressing cancer cells. PSMA PET is used to help determine whether a patient's cancer has sufficient PSMA expression for this type of treatment. Depending on the clinical situation, scan findings may also prompt conversations about chemotherapy, targeted radiation, clinical trials, or other therapies. Ultimately, a PSMA scan does not, however, provide a treatment decision by itself.
When a Referral or Specialist Consultation May Be Recommended
When a PSMA PET scan provides new information about where prostate cancer is located or how widely it has spread, your care team may recommend meeting with another specialist to better understand what the findings could mean for your treatment. A urologist may help put the scan findings in the context of your original diagnosis and previous treatments. A medical oncologist may discuss systemic treatments, such as hormone therapy, chemotherapy, targeted therapies, or other medications.
If the scan identifies a limited number of areas of cancer, a radiation oncologist may be asked whether targeted radiation could be appropriate. A nuclear medicine physician or radiologist plays an important role in interpreting PSMA imaging and may also be involved when PSMA-targeted radioligand therapy is being considered. Importantly, a referral does not necessarily mean that your cancer has suddenly become more serious or that your treatment must change. Instead, it may provide an opportunity to bring together different areas of expertise and consider the full range of available options. The goal is to match what the scan shows and to develop an individualized plan.
Questions to Ask After Your PSMA Scan
Receiving the results of a PSMA PET scan can bring both answers and new questions. The most important first step is understanding what the scan showed and what those findings may mean for you. PSMA PET can provide a detailed map of where prostate cancer may be located, but no imaging test is perfect. Patients and care partners may find it helpful to ask:
- Where did the scan show prostate cancer, and how confident are you about each finding?
- Has the cancer spread to new areas, such as lymph nodes, bones, or other organs?
- How does this scan compare with my previous imaging?
- Does the scan change how you would describe the extent or stage of my cancer?
- Do any findings need confirmation with another scan, MRI, or biopsy?
- Does my cancer appear sufficiently PSMA-positive to consider PSMA-targeted radioligand therapy?
- Could any areas be treated individually with radiation or another targeted approach?
- Does this result change what treatment you recommend now, or the order of treatments we may consider?
- Should I meet with another specialist or a multidisciplinary prostate cancer team?
- If we do not change treatment now, when should we repeat imaging or reassess?
Key Takeaway for Patients and Care Partners
PSMA imaging can provide valuable information about where prostate cancer is located and may open the door to additional treatment options. However, understanding the scan is only one part of planning what comes next. Patients and care partners should consider the following 3 key takeaways:
Know what comes next: Ask your care team how your PSMA scan results may affect your treatment plan, including what treatment is being considered, when it would start, and what follow-up testing or appointments will be needed.
Plan for the practical side of treatment: Some treatments may require travel to a specialized center, multiple appointments, laboratory testing, or temporary radiation-safety precautions - for example, temporarily limiting close contact with others, using extra bathroom hygiene practices, and avoiding prolonged close contact with children or pregnant individuals for a period after treatment. Consider transportation, work schedules, caregiver support, insurance coverage and prior authorization requirements, potential out-of-pocket costs, and time away from home when discussing your options.
Make the decision together: PSMA imaging provides important information, but the scan alone does not determine your treatment. Your care team should consider the imaging results together with your previous treatments, symptoms, overall health, personal preferences, and quality-of-life goals when deciding on the next step.
Know where to find support: You do not have to navigate this alone. Prostate Cancer Patient Voices, patient advocacy organizations, and financial assistance programs offered by hospitals, drug manufacturers, or nonprofit foundations may be able to help with education, emotional support, and cost-related concerns. Ask your care team or a social worker/patient navigator which resources may fit your situation.
